Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 58 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Retrospective Populations Clear all

Conditions: Alopecia Areata
Interventions: Ritlecitinib; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: LCAT Deficiency
Interventions: Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam, country of residence.; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: Not listed
Enrollment: 40 participants
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Myocardial Infarction (AMI)
Interventions: Not listed
Lead sponsor: Rohan Dharmakumar; Other
Eligibility: 18 Years to 79 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Postpartum Preeclampsia
Interventions: Tight postpartum blood pressure control; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older · Female only
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Livingston, New Jersey • New Brunswick, New Jersey

Conditions: Chronic Illness
Interventions: ICC (Integrated Care Coaching) Intervention Group; Behavioral
Lead sponsor: Scott & White Health Plan; Industry
Eligibility: 18 Years and older
Enrollment: 17,559 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Plaque Psoriasis
Interventions: Secukinumab; Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 277 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: HCV Infection
Interventions: Glecaprevir/pibrentasvir; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hepatitis C, Substance Use Disorders, Substance Abuse, Intravenous
Interventions: elbasvir-grazoprevir (50 mg/100 mg); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Portland, Oregon

Conditions: Cleft Lip and Palate
Interventions: Comparator: Retrospective Group(Control), Prospective Group; Other · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Up to 6 Months
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Kidney Disease
Interventions: collection of serum/capillary creatinine values; Diagnostic Test
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 19
States / cities: Huntsville, Alabama • Victorville, California • Bloomfield, Connecticut + 14 more

Conditions: Adverse Pregnancy Outcomes, Atopic Dermatitis
Interventions: dupilumab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 12,343 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Shoulder Pain, Shoulder Injuries, Shoulder Fractures, Shoulder Disease, Shoulder Arthritis
Interventions: Comprehensive Primary Revision Stems; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2040
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ischemic Stroke, TIA, Hemorrhage
Interventions: Not listed
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 25,586 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Lexington, Massachusetts

Conditions: Pancreatic Cancer
Interventions: Blood Sample Collection, Tissue Sample Collection, Data Collection, Medical Image Collection; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Tampa, Florida • Jackson, Mississippi

Conditions: Atrial Fibrillation
Interventions: Observational; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 38,499 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: HIV Infection
Interventions: Not listed
Lead sponsor: Gilead Sciences; Industry
Eligibility: Female only
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Hearing Loss, Sensorineural
Interventions: MED-EL SYNCHRONY PIN Cochlear Implant, Cochlear Implant; Device · Other
Lead sponsor: Med-El Corporation; Industry
Eligibility: 7 Months to 5 Years
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: Oakland, California • Miami, Florida • Chicago, Illinois + 5 more

Conditions: Ulcerative Colitis, Pediatric, Inflammatory Bowel Diseases, Crohn Disease
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 1 Year to 18 Years
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 4
States / cities: Chapel Hill, North Carolina • Charlotte, North Carolina • Durham, North Carolina + 1 more

Conditions: COVID-19, Proning, Oxygenation, Length of Stay
Interventions: Proning group, Control group; Other
Lead sponsor: Baylor St. Luke's Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sexually Transmitted Disease (STD), Gonorrhea, Chlamydia, Trichomonas Infection
Interventions: Self-swab collection PCR test for chlamydia, gonorrhea, trichomonas; Diagnostic Test
Lead sponsor: Queen's Medical Center; Other
Eligibility: 14 Years and older · Female only
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Inguinal Hernia, Surgery--Complications, Surgical Complication
Interventions: Bassini hernia repair; Procedure
Lead sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Critically Ill Children
Interventions: Peptide-based enteral formula, Retrospective review of enteral tube feeding formula; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 1 Year to 13 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Chicago, Illinois • Memphis, Tennessee

Conditions: Congenital Disorders
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: Up to 21 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study

Acute MI UDMI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

Management of Postpartum Preeclampsia

Retrospective Data Analysis of VitalCare Targeted Population Management on Scott and White Chronically Ill Beneficiaries

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)

Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care

DynaCleft® Effects on Soft Tissues and on Quality of Life for Incomplete Unilateral Cleft Lip Infants

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

MDR - Comprehensive Primary Revision Stems PMCF

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication

Expanded Indications in the MED-EL Pediatric Cochlear Implant Population

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Non-ventilated Prone Positioning in the COVID-19 Population

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

Bassini Inguinal Hernia Repair: Obsolete Or Still A Viable Surgical Option?

Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding

Biventricular Pacing in the Pediatric Population